Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.

Farooqi JQ, Jabeen K, Saeed N, Iqbal N, Malik B, Lockhart SR, Zafar A, Brandt ME, Hasan R.

J Med Microbiol. 2013 Feb;62(Pt 2):259-68. doi: 10.1099/jmm.0.048785-0. Epub 2012 Oct 25.

2.

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.

J Antimicrob Chemother. 2015 Mar;70(3):802-10. doi: 10.1093/jac/dku460. Epub 2014 Dec 3.

PMID:
25473027
3.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
5.

Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010-2011.

Maldonado NA, Cano LE, De Bedout C, Arbeláez CA, Roncancio G, Tabares AM, Robledo CG, Robledo J; Grupo GERMEN.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):280-6. doi: 10.1016/j.diagmicrobio.2014.02.003. Epub 2014 Feb 22.

PMID:
24666706
6.

Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.

Nieto MC, Tellería O, Cisterna R.

Diagn Microbiol Infect Dis. 2015 Jan;81(1):34-40. doi: 10.1016/j.diagmicrobio.2014.05.021. Epub 2014 Jun 5.

PMID:
25439581
7.

In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.

Amran F, Aziz MN, Ibrahim HM, Atiqah NH, Parameswari S, Hafiza MR, Ifwat M.

J Med Microbiol. 2011 Sep;60(Pt 9):1312-6. doi: 10.1099/jmm.0.027631-0. Epub 2011 Apr 1.

PMID:
21459913
8.

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.

Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02045-16. doi: 10.1128/AAC.02045-16. Print 2017 Mar.

9.

Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.

Liu W, Tan J, Sun J, Xu Z, Li M, Yang Q, Shao H, Zhang L, Liu W, Wan Z, Cui W, Zang B, Jiang D, Fang Q, Qin B, Qin T, Li W, Guo F, Liu D, Guan X, Yu K, Qiu H, Li R; China-SCAN team.

J Antimicrob Chemother. 2014 Jan;69(1):162-7. doi: 10.1093/jac/dkt330. Epub 2013 Sep 4.

PMID:
24004860
10.

Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.

Pu S, Niu S, Zhang C, Xu X, Qin M, Huang S, Zhang L.

J Microbiol Immunol Infect. 2017 Feb;50(1):97-103. doi: 10.1016/j.jmii.2015.01.005. Epub 2015 Jan 30.

11.
12.

Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.

Aguilar G, Delgado C, Corrales I, Izquierdo A, Gracia E, Moreno T, Romero E, Ferrando C, Carbonell JA, Borrás R, Navarro D, Belda FJ.

BMC Res Notes. 2015 Sep 29;8:491. doi: 10.1186/s13104-015-1458-4.

13.

Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.

Wang H, Xu YC, Hsueh PR.

Future Microbiol. 2016 Oct;11:1461-1477. Epub 2016 Oct 18. Review.

PMID:
27750452
14.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group.

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
15.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D; FUNGEMYCA Study Group.

Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6. doi: 10.1128/AAC.00466-11. Epub 2011 Sep 19.

16.

Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.

Ozhak-Baysan B, Ogunc D, Colak D, Ongut G, Donmez L, Vural T, Gunseren F.

Med Mycol. 2012 Jul;50(5):529-32. doi: 10.3109/13693786.2011.618996. Epub 2011 Oct 11.

PMID:
21988703
17.

Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.

Borghi E, Sciota R, Iatta R, Biassoni C, Montagna MT, Morace G.

Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1437-41. doi: 10.1007/s10096-011-1242-x. Epub 2011 Apr 10.

PMID:
21479840
18.

Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P, Meis JF, Boekhout T.

Infection. 2014 Apr;42(2):393-404. doi: 10.1007/s15010-013-0570-4. Epub 2013 Dec 19.

PMID:
24352810
19.

In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Diekema DJ, Messer SA, Boyken LB, Hollis RJ, Kroeger J, Tendolkar S, Pfaller MA.

J Clin Microbiol. 2009 Oct;47(10):3170-7. doi: 10.1128/JCM.00942-09. Epub 2009 Aug 26.

20.

Supplemental Content

Support Center